Description: Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. It offers human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, women's health and endocrine, inflammatory and infectious diseases, oncology, ophthalmology, and others. The company also provides vaccines, including preventive pediatric, adolescent, and adult vaccines. In addition, it discovers, develops, manufactures, and markets animal health products comprising vaccines, antibiotics, and anti-inflammatory drugs for respiratory diseases, as well as products for the treatment of fertility disorders. Further, the company manufactures and sells over-the-counter products consisting of non-drowsy antihistamines; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant spray; and products for occasional constipation and frequent heartburn. Additionally, it offers foot care products, including topical antifungal, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, and dry oils. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, food chain and mass merchandiser outlets, club stores, and specialty channels, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. It has a collaboration with Sanofi Pasteur S.A. and Abide Therapeutics, Inc.; and has a collaboration and license agreement with Luminex Corporation. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.
Home Page: www.merck.com
MRK Technical Analysis
2000 Galloping Hill Road
Kenilworth,
NJ
07033
United States
Phone:
908 740 4000
Officers
| Name | Title |
|---|---|
| Mr. Robert M. Davis J.D. | CEO & Chairman |
| Ms. Caroline Litchfield | Exec. VP & CFO |
| Mr. Richard R. DeLuca Jr. | Exec. VP & Pres of Merck Animal Health |
| Dr. Dean Y. Li M.D., Ph.D. | Exec. VP & Pres of Merck Research Laboratories |
| Mr. David Michael Williams | Exec. VP and Chief Information & Digital Officer |
| Mr. Peter Dannenbaum | VP of Investor Relations |
| Ms. Jennifer L. Zachary | Exec. VP & Gen. Counsel |
| Lisa LeCointe-Cephas | Sr. VP and Chief Ethics & Compliance Officer |
| Ms. Jennifer Mauer | VP of Global Communications |
| Ms. Cristal N. Downing | Exec. VP and Chief Communications & Public Affairs Officer |
Exchange: NYSE
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 14.7493 |
|---|---|
| Trailing PE: | 18.3765 |
| Price-to-Book MRQ: | 6.3616 |
| Price-to-Sales TTM: | 4.7132 |
| IPO Date: | 1978-01-13 |
| Fiscal Year End: | December |
| Full Time Employees: | 67000 |